Table 1 Summary of studies included in the review
From: Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Reference | Country | Population | Population Size | Birth Incidence | Prevalence Rate |
|---|---|---|---|---|---|
NF1 Studies using medical records | |||||
Huson et al., 1988 [13] | United Kingdom | All residents of South-East Wales, age range of 11 months to 83 years. | 668,100 | NA | 1/4949 |
Samuelsson et al., 1989 [14] | Sweden | All residents of Gothenburg, Sweden, age range of 20 + years. | 337,979 | NA | 1/4600 |
Poyhonen et al., 2000 [16] | Finland | All residents of Northern Finland, age range 3 months to 73 years (mean 29 years). | 733,037 | 1/3647 | 1/4436 |
Evans et al., 2010 [6] | United Kingdom | All residents of Northwest England. | 3,050,409 | 1/2712 | 1/4560 |
Uusitalo et al., 2015 [20] | Finland | All residents of Finland. | 5,400,000 | 1/1871 | NA |
Kallionpaa et al.,2018 [5] | Finland | All residents of Finland. | 5,228,552 | NA | 1/4088 |
NF1 studies using screening | |||||
Garty et al., 1994 [15] | Israel | Jewish recruits for military service, aged 17 years. | 374,440 | NA | 1/960 |
Lammert et al., 2005 [17] | Germany | Children aged 6 years. | 152,819 | NA | 1/2996 |
InGordo et al., 2007 [18] | Italy | Military recruits, men. | 34,740 | NA | 1/5735 |
Orraca et al., 2014 [19] | Cuba | Children aged 9–11 years. | 19,392 | NA | 1/1141 |
NF2 studies using medical records | |||||
Antinheimo et al., 2000 [21] | Finland | All residents in the catchment area of Helsinki University Central Hospital. | 1,713,000 | 1 in 87,410 | NA |
Evans, 1992 [8] | United Kingdom | All residents of the Northwest Regional Health Authority catchment area. | 4,016,000 | 1 in 40,562 | 1 in 216,110 |
Evans et al., 2010 [6] | United Kingdom | All residents of Northwest England. | 3,050,409 | 1 in 33,209 | 1 in 56,161 |
Uusitalo et al., 2015 [20] | Finland | All residents of Finland. | 5,400,000 | 1 in 39,336 | NA |